Delivery Order SPE2DB24D1205-SPE2DB25FCXBW
- Not listed
- The Defense Logistics Agency awarded a $14,609.25 delivery order to AmerisourceBergen Drug Corp for supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract. The award, issued on November 3, 2025, with completion expected by November 25, 2025, represents a non-competitive set-aside delivery order executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is a child contract under the larger SPE2DX...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $4,466.57 firm fixed price delivery order contract to supply Zeposia 0.92 mg capsules. This order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,739.52 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count packages) on November 7, 2025, with completion scheduled for December 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,620.94 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count package) under a firm fixed price arrangement. This non-competitive, non-set-aside delivery order was awarded on October 28, 2025, with an ultimate completion date of November 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $13,862.79 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count) under a firm fixed price contract. The award, issued on September 26, 2025, with an ultimate completion date of October 20, 2025, represents a non-competitive, competitively awarded transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract valued at $13,862.79. This non-set-aside competitive award, with an ultimate completion date of August 18, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $13,862.79 to AmerisourceBergen Drug Corp for Zeposia 0.92 mg capsules (30-count) on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,483.72 for Zeposia 0.92 mg capsules (30-count) on September 24, 2025, with completion scheduled for October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,620.93 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zeposia 0.92 mg capsules (30-count packaging). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by October 7, 2025. The contractor will perform fulfillment from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,869.75 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count units) on November 5, 2025, with completion scheduled for November 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXBWDelivery Order
The Defense Logistics Agency awarded a $13,862.79 delivery order to AmerisourceBergen Drug Corp for supply of Zeposia 0.92 mg capsules (30-count units) with a completion date of June 17, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, the vendor's corporate headquarters. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. As a critical vendor within DLA's Medical Supply Chain, the company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains. This delivery order for Zeposia, a neurological treatment medication, exemplifies the company's role in supporting Defense Health Agency and other government healthcare systems through competitive, firm fixed-price transactions that demonstrate its capability to meet federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 5/27/25 |